US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 9.990
  • +0.190+1.94%
Trading Sep 17 10:30 ET
242.63MMarket Cap-7460P/E (TTM)

Artiva Biotherapeutics Key Stats

Artiva Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 75.000K--
--2024/Q3-- / 75.000K--
--2024/Q20.000 / 75.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 75.000K--
--2024/Q3-- / 75.000K--
--2024/Q20.000 / 75.000K--
--------
--------

Unlock Free Earnings Estimates

Artiva Biotherapeutics Earnings Reports

Analysis

Analyst Rating

Updated: Aug 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data